Novel Anthracycline Utorubicin for Cancer Therapy-Reference-Cited by-同舟云学术

Novel Anthracycline Utorubicin for Cancer Therapy

Published:2021-06 Issue:31 Volume:133 Page:17155-17164
ISSN:0044-8249
Container-title:Angewandte Chemie
language:en
Short-container-title:Angew. Chem.

Author:

Simón‐Gracia Lorena¹^ORCID,Sidorenko Valeria¹^ORCID,Uustare Ain²,Ogibalov Ivan²,Tasa Andrus²,Tshubrik Olga²,Teesalu Tambet¹³⁴^ORCID

Affiliation:

1. Institute of Biomedicine and Translational Medicine University of Tartu Ravila 14b 50411 Tartu Estonia

2. Toxinvent LLC Tiigi 61b 50410 Tartu Estonia

3. Cancer Research Center Sanford-Burnham-Prebys Medical Discovery Institute 10901 North Torrey Pines Road La Jolla CA 92037 USA

4. Center for Nanomedicine and Department of Cell Molecular and Developmental Biology University of California Santa Barbara Santa Barbara CA 93106 USA

Funder

Sihtasutus Archimedes

European Regional Development Fund

H2020 European Research Council

Wellcome Trust

Eesti Teadusagentuur

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.202016421

Reference56 articles.

1. Anthracycline Chemotherapy and Cardiotoxicity

2. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

3. DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

4. Anthrazykline in der Krebstherapie

5. Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-end rule peptide-guided niosomes for prostate cancer cell targeting;Journal of Drug Delivery Science and Technology;2024-01

2. Therapeutic Potential of CPPs;CPP, Cell-Penetrating Peptides;2023

3. Targeting triple-negative breast cancer with β1-integrin binding aptamer;2022-07-28